Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions 06/16/2016 INTERVENTIONAL unchanged 3,723.85 0 BMI-based Vitamins in Obese Pregnant Women 06/16/2016 INTERVENTIONAL unchanged 3,723.85 0 KOrean Borderline Ovarian Tumor (KOBOT) Registry 06/17/2016 OBSERVATIONAL unchanged 3,722.85 0 Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia 06/17/2016 INTERVENTIONAL unchanged 3,722.85 0 Ovarian Cancer Hemoscope Trial 06/23/2016 OBSERVATIONAL unchanged 3,716.85 0 Dried Plums and Bone Health in Postmenopausal Women 07/04/2016 INTERVENTIONAL unchanged 3,705.85 0 Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer 07/11/2016 INTERVENTIONAL unchanged 3,698.85 0 Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer 07/11/2016 INTERVENTIONAL unchanged 3,698.85 0 Trial on Radical Upfront Surgery in Advanced Ovarian Cancer 07/11/2016 INTERVENTIONAL unchanged 3,698.85 0 Observational Study on Endometrial Stromal Tumors 07/12/2016 OBSERVATIONAL unchanged 3,697.85 0 A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls 07/15/2016 INTERVENTIONAL unchanged 3,694.85 0 Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer 07/21/2016 INTERVENTIONAL unchanged 3,688.85 0 Advanced Fetal Imaging - Phase II 07/21/2016 INTERVENTIONAL unchanged 3,688.85 0 Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY) 08/08/2016 INTERVENTIONAL unchanged 3,670.85 0 Institut Paoli Calmettes Cervical Cancer Database 08/17/2016 OBSERVATIONAL unchanged 3,661.85 0 Institut Paoli Calmettes Ovarian Cancer Database 08/17/2016 OBSERVATIONAL unchanged 3,661.85 0 Bladder Directed vs. Pelvic Floor Therapy in IC/BPS 08/17/2016 INTERVENTIONAL unchanged 3,661.85 0 Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation 08/18/2016 INTERVENTIONAL unchanged 3,660.85 0 Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS) 08/18/2016 INTERVENTIONAL unchanged 3,660.85 0 A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib 08/22/2016 INTERVENTIONAL unchanged 3,656.85 0 Use of a Squatting Assist Device in Patients With Constipation 08/24/2016 INTERVENTIONAL unchanged 3,654.85 0 Fertility Preservation in Young Women With Cancer 08/25/2016 OBSERVATIONAL unchanged 3,653.85 0 Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer 08/30/2016 INTERVENTIONAL unchanged 3,648.85 0 Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery 08/31/2016 INTERVENTIONAL unchanged 3,647.85 0 Hong Kong Breast Cancer Study 09/05/2016 OBSERVATIONAL unchanged 3,642.85 0 EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer 09/07/2016 INTERVENTIONAL unchanged 3,640.85 0 Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer 09/07/2016 INTERVENTIONAL unchanged 3,640.85 0 Persistent Organic Pollutants and Breast Cancers (POPCASE) 09/07/2016 INTERVENTIONAL unchanged 3,640.85 0 The French National Reference Centre of GTD 09/08/2016 OBSERVATIONAL unchanged 3,639.85 0 Bergonie Institute Breast Cancer Database 09/08/2016 OBSERVATIONAL unchanged 3,639.85 0 PREgnancy and FERtility Registry 09/09/2016 OBSERVATIONAL unchanged 3,638.85 0 Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome 09/12/2016 OBSERVATIONAL unchanged 3,635.85 0 A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast 09/13/2016 INTERVENTIONAL unchanged 3,634.85 0 Vaginal and Oral Microbiome Crosstalk 09/13/2016 OBSERVATIONAL unchanged 3,634.85 0 Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer 09/23/2016 INTERVENTIONAL unchanged 3,624.85 0 Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer 09/23/2016 INTERVENTIONAL unchanged 3,624.85 0 Accelerated Radiation Therapy (ART) to the Breast and Nodal Stations 09/28/2016 INTERVENTIONAL unchanged 3,619.85 0 Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes 09/28/2016 OBSERVATIONAL unchanged 3,619.85 0 Predictors of De-novo Development of Obstructive Sleep Apnea in Pregnancy 09/28/2016 OBSERVATIONAL unchanged 3,619.85 0 CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer 09/28/2016 INTERVENTIONAL unchanged 3,619.85 0 Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer 09/29/2016 INTERVENTIONAL unchanged 3,618.85 0 Memory Gel and Shape Combined Cohort 09/29/2016 INTERVENTIONAL unchanged 3,618.85 0 Transvaginal Ultrasound Cervical Length Screening in Singleton Pregnancy With Prior Spontaneous Preterm Birth 10/05/2016 INTERVENTIONAL unchanged 3,612.85 0 Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy 10/06/2016 INTERVENTIONAL unchanged 3,611.85 0 Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS 10/06/2016 INTERVENTIONAL unchanged 3,611.85 0 Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction 10/07/2016 INTERVENTIONAL unchanged 3,610.85 0 Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts 10/14/2016 INTERVENTIONAL unchanged 3,603.85 0 Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer 10/24/2016 INTERVENTIONAL unchanged 3,593.85 0 Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy 10/26/2016 INTERVENTIONAL unchanged 3,591.85 0 Pregnancy Outcomes: Effects of Metformin Study (POEM Study) 10/28/2016 INTERVENTIONAL unchanged 3,589.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology